3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
3
Neoplasms
2
Carcinoma, Renal Cell
2
Uterine Cervical Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Recurrence
1
Ovarian Neoplasms
1
Neoplasms, Second Primary
1
NSCLC
1
Lung Neoplasms
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Biphenotypic, Acute
1
Kidney Neoplasms
1
Gastro Intestinal Stromal Tumor
1
Endometrial Neoplasms
1
Congenital Abnormalities
1
Asymptomatic Brain Metastases
1
Interventions
Bevacizumab
7
Capecitabine
4
Cetuximab
3
trifluridine tipiracil drug combination
2
Nivolumab
2
Fluorouracil
2
sintilimab
1
regorafenib
1
irinotecan sucrosofate
1
folfirinox
1
balstilimab
1
Vemurafenib
1
Transurethral Resection of Prostate
1
Tomography, X-Ray Computed
1
Panitumumab
1
Liver Transplantation
1
Ipilimumab
1
Immune Checkpoint Inhibitors
1
HMPL-013
1
Folfox protocol
1
Doxorubicin
1
Decitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Colorectal Cancer Metastatic
×
Tyrosine Kinase Inhibitors
×
1 year
×
Clear all
No trials found.